{"product_id":"tead1-tead2-tead3-tead4-antibody-sc-f0747","title":"Pan-TEAD Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003ePan-TEAD is a target of interest in many antibody-based workflows. Transcriptional Enhanced Associate Domain (TEAD) transcription factors play pivotal roles in various biological processes including development, cell proliferation, tissue regeneration, and maintaining tissue equilibrium. They act as central hubs that integrate and coordinate signals from multiple pathways such as Hippo, Wnt, TGFβ, and EGFR. Dysregulation of TEAD impacts several well-known cancer-associated genes like KRAS, BRAF, LKB1, NF2, and MYC, thereby influencing tumor progression, metastasis, metabolism, immune responses, and resistance to drugs. Depending on the literature source, Pan-TEAD may also be discussed as Pan-TEAD and TEAD-2.\u003c\/p\u003e\u003cp\u003eReported cellular context includes nucleus, which can matter when signal is compared across treatments or changing cell states. Following Pan-TEAD across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003ePan-TEAD is commonly interpreted in the context of cancer, developmental biology, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003esignal enrichment within nucleus relative to the broader cellular background\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003estage-dependent patterns during differentiation, morphogenesis, or lineage commitment\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Pan-TEAD. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Pan-TEAD reflect biology rather than handling. When interpreting Pan-TEAD, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep Pan-TEAD trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577512075609,"sku":"F0747-20UL","price":169.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577512108377,"sku":"F0747-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577512141145,"sku":"F0747-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0747-wb.gif?v=1773598872","url":"https:\/\/absource.de\/products\/tead1-tead2-tead3-tead4-antibody-sc-f0747","provider":"Absource Diagnostics","version":"1.0","type":"link"}